Detalhe da pesquisa
1.
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis.
J Autoimmun
; 88: 61-74, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29054368
2.
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.
Clin Immunol
; 166-167: 1-11, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27050759
3.
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(3)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810163
4.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
J Neurol Neurosurg Psychiatry
; 83(8): 796-802, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22693287
5.
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8+ Regulatory T Cells.
Neurol Neuroimmunol Neuroinflamm
; 9(6)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266052